UPL Ltd

- No explicit mention of immediate or planned new fundraising through debt or equity in the provided pages. - The company has been actively deleveraging, reducing gross debt by $850 million and net debt by $400 million in recent periods. - They redeemed $400 million perpetual bonds using internal cash and extended a $400 million loan maturity to March 2029. - Created a $300 million committed revolving credit facility as a liquidity cushion but not as new debt raising. - Focus remains on maintaining a comfortable net debt to EBITDA ratio (~1.5x) and cautious capital structure management. - Excess cash generated will be used primarily for deleveraging, capex (increased to $300-350 million), and selectively evaluated M&A opportunities. - No direct plans stated for equity fundraising; prior rights issue proceeds of $200 million mentioned without new planned equity raise.

- For the upcoming year, UPL plans to increase capex to approximately $300 million to $350 million (around $325 million), up from $261 million in the current year. - The company sees significant opportunities in specialty chemicals, with many global players seeking long-term contracts to source UPL's capacity. - There are plans for backward integration investments to enhance margin profiles and build additional EBITDA. - The capex increase aims to capitalize on growth opportunities and improve overall margin resilience. - Past disciplined capex led to reduced fixed assets due to depreciation but strengthened the balance sheet. - UPL remains focused on capital efficiency, cash flow, and maintaining an optimal capital structure.

- UPL expects total cropland in the next 12 months to be at or larger than the previous 12 months, supporting stable or growing crop protection volumes despite crop switches. - Volume growth is anticipated across key platforms: India SAS business, Advanta, and SUPERFORM specialty chemicals. - SUPERFORM specialty chemicals projected to grow over 20% annually, with Ag business growing 6%-10%; specialty expected to form 40% of business in 48 months. - FY27 revenue growth guidance: Q1 revenue expected to grow 10%-14%, driven by volume growth in multiple segments and 7%-9% positive FX impact. - Innovation-driven growth emphasized with over 100 new products launching in FY27, targeting $115 million in new revenue. - Strong volume-driven growth seen globally: 23% in Q4 rest of the world, 21% in Latin America, 18%-21% in North America and Europe. - Focus on differentiated and sustainable products (NPP portfolio) expected to support continued volume and revenue growth.

- Q1 FY27 revenue growth guidance: 10% to 14%, with EBITDA growth guidance between 14% to 18% (Page 24). - Full-year FY26 EBITDA margin near 19%, close to 20% excluding one-off provisions; Q1 margins typically lower due to seasonality but expected to improve in later quarters (Page 24). - Specialty segment expected to grow over 20%, Ag segment 6%-10%; platform mix will shift to 40% specialty and 60% Ag in 48 months enabling ~20% EBITDA margin (Page 32). - Cautiously optimistic for FY27, with operating leverage and volume growth driving earnings (Pages 24, 33). - Focus on quality of earnings, cost rationalization, improving plant utilization, and capital efficiency to sustain margin expansion and profit growth (Pages 23, 24, 33). - Anticipated increase in capex (~$300-$350 million) to support growth and margin resilience (Page 32). - Long-term seed business in India expected to sustain growth driven by hybridization and increased seed replacement (Page 33).

- UPL does not take advanced orders as it did 2-3 years ago; distribution now buys closer to the season. - In Brazil, farmers plant soybeans around September-October; channel negotiates deliveries in July-August. - Q1 in Brazil is mostly small in-season business; Q2 is when stocking for the upcoming season starts. - The whole market in Brazil has shifted to a just-in-time model, and UPL has adapted its business accordingly. - No specific numerical figures for current or expected order book/pending orders were provided in the document.